Breast Cancer Clinical Trial
Role of 3D Tomography in Breast Cancer
Summary
The primary aim of this pilot study is to define the role of dedicated cone beam breast computed tomography in breast cancer imaging. This research is a prelude of a more comprehensive clinical trial that may follow.
Eligibility Criteria
Inclusion Criteria:
All women, age 40 or older, who are scheduled for biopsy after classification as BI-RADS 4/5 and have had a screening or diagnostic full-field digital mammography (FFDM) exam are eligible to participate, except for exclusions noted below.
Able to provide informed consent.
Exclusion Criteria:
Males
Women less than 40 years old
Pregnant women
Lactating women
Woman who have had bilateral mastectomies
Women with physical limitations that may prohibit resting prone on the exam table, such as, but not limited to: frozen shoulder, recent heart surgery, pace maker
Women who are unable to tolerate study constraints, frail or unable to cooperate
Women with large breasts that cannot be accommodated within the field of view of the CT system
Women who have received radiation treatments to the thorax for malignant and nonmalignant conditions, such as (but not limited to)
Treatment for enlarged thymus gland as an infant
Irradiation for benign breast conditions, including breast inflammation after giving birth
Treatment for Hodgkin's disease
Women who have participated in a prior breast clinical trial that gave additional radiation dose, such as an additional mammogram.
Women who have received large numbers of diagnostic x-ray examinations for monitoring of disease such as (but not limited to)
Tuberculosis
Severe scoliosis
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Rochester New York, 14623, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.